Table 3.
Event/GOLD | Off treatment | Tiotropium | Glycopyrronium | ||||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
II | III | IV | II | III | IV | II | III | IV | |
No exacerbation | 0.84 | 0.78 | 0.73 | 0.87 | 0.81 | 0.77 | 0.86 | 0.79 | 0.74 |
Nonsevere exacerbation | 0.14 | 0.17 | 0.18 | 0.11 | 0.14 | 0.15 | 0.11 | 0.14 | 0.14 |
Severe exacerbation | 0.02 | 0.05 | 0.08 | 0.02 | 0.05 | 0.08 | 0.03 | 0.07 | 0.12 |
Notes: Usual care probabilities from UPLIFT were used in cycles off treatment. Probabilities reflect 3-month risks. Data from Hettle et al27 (derived from UPLIFT), SPARK,19 and own calculations.
Abbreviations: GOLD, Global Initiative for Chronic Obstructive Lung Disease; UPLIFT, Understanding Potential Long-term Impacts on Function with Tiotropium.